-
Bayer soars on promising trial results for stroke prevention drug
Findings are respite for German conglomerate facing sliding sales of blockbuster drugs and US legal
-
UK life insurers clear stress tests as private capital influx raises concerns
Sector deemed resilient even as a wave of investment raises fears over future vulnerability
-
Novo Nordisk shares slump after drug failure in Alzheimer’s trial
Outcome is blow to one of Europe’s largest listed companies
-
The Trump team’s tortured path to a Ukraine peace plan
Washington’s mixed signals and shifting proposals unsettle allies as negotiations near a critical phase
-
‘Keir Starmer is not on the ballot paper in this election’, says Welsh first minister
Labour’s Eluned Morgan distances herself from national government ahead of Senedd ballot in May
-
What big bond investors want from the UK Budget
Gilt market players call on government to cut spending and steer clear of inflationary tax
-
FT seasonal appeal: why financial education has never been more crucial
Experian will match-fund reader donations to bring FLIC’s financial literacy to more people
-
How to get the UK out of its economic hole
Reeves’ challenge is to remedy the disaster that Brexit has been for the country
Recent Posts
- Supreme Court allows Texas electoral map that favours Republicans
- Donald Trump announces ‘historic’ peace treaty between Rwanda and DR Congo
- US admiral defends second strike on alleged drug boat in Caribbean
- UK workers set to get unlimited compensation for unfair dismissal
- Trustpilot shares plummet after short seller alleges ‘mafia-style’ practices
